Abstract：
The Woven EndoBridge (WEB) and other intrasaccular flow disruptors show promise in treating intracranial aneurysms. We performed a bibliometric analysis to provide novel insights into the trends and trajectory of these devices. We systematically assessed bibliometric data such as citations, journals, study designs, open access status, and multi-institutional involvement for the top-cited articles on WEB and other disruptors. The top 100 cited studies on the WEB had citations from 7 to 144 (mean ± standard deviation 35.6 ± 29.5), while only 33 studies were published for other intrasaccular flow disruptors (4.24 ± 8.45). Of the other devices, the Contour has the most publications (n = 21). Retrospective reviews were the most common study design for both WEB and other intrasaccular devices. France published the most studies in the top 100 WEB papers (n = 35), while Germany led for other flow disruptors (n = 10). In all studies analyzed, no senior authors from Africa are present. The top 100 WEB publications had a higher mean citation count (35.6 vs. 4.24, P<0.001), higher mean citations per year (5.24 vs. 1.03, P<0.01), and a higher proportion of multi-institutional collaborations (44.0% vs. 12.1%, P<0.01) than other intrasaccular flow disruptors. In conclusion, countries with the most publications on WEB are not necessarily the ones leading the way with newer intrasaccular devices, while study designs remain similar. There is a limited contribution to the literature outside of Europe and North America. Our findings identify notable collaborators and trends, providing a snapshot of the field and a roadmap for future research.
摘要：
编织的EndoBridge（WEB）和其他囊内血流破坏剂在治疗颅内动脉瘤方面显示出希望。我们进行了文献计量分析，以提供对这些设备的趋势和轨迹的新颖见解。我们系统地评估了文献计量数据，如引文，期刊,研究设计，开放访问状态,以及多机构参与WEB上引用最多的文章和其他破坏者。WEB上引用的前100项研究的引用次数从7到144（平均值±s.d.35.6±29.5），而其他囊内血流干扰物的研究只有33项(4.24±8.45)。在其他设备中，轮廓有最多的出版物（n=21）。回顾性审查是最常见的研究设计WEB和其他肿瘤内设备。法国在排名前100位的WEB论文中发表了最多的研究（n=35），而德国领先于其他流量干扰者(n=10)。在所有分析的研究中，没有来自非洲的资深作者出席。排名前100位的WEB出版物的平均引文计数较高（35.6与4.24，p<0.001)，每年平均引用次数较高(5.24与1.03，p<0.01），多机构合作的比例更高(44.0%与12.1%,p<0.01）比其他囊内流动干扰物。总之,网站上出版物最多的国家不一定是采用较新的细胞内设备的国家，而研究设计保持相似。对欧洲和北美以外的文学贡献有限。我们的发现确定了值得注意的合作者和趋势，提供该领域的快照和未来研究的路线图。
